Teladoc (TDOC) Stock Drops Despite Market Gains: Important Facts to Note

Company Performance - Teladoc's stock closed at $7.49, down 3.97%, underperforming the S&P 500's daily gain of 0.3% [1] - Over the past month, Teladoc shares appreciated by 13.54%, outperforming the Medical sector's gain of 7.07% and the S&P 500's gain of 2.09% [1] Earnings Projections - The upcoming earnings release projects an earnings per share (EPS) of -$0.24, a 26.32% decrease from the same quarter last year [2] - The Zacks Consensus Estimate for revenue is $625.56 million, down 2.33% from the year-ago period [2] Full Year Estimates - For the full year, the Zacks Consensus Estimates project an EPS of -$1.17 and revenue of $2.52 billion, reflecting changes of +80.07% and -1.82% respectively from the preceding year [3] - Recent changes to analyst estimates indicate a shifting business landscape, with positive revisions suggesting optimism about the business outlook [3] Zacks Rank and Industry Position - The Zacks Rank system, which assesses estimate changes, currently ranks Teladoc as 3 (Hold) [5] - The Medical Services industry, part of the Medical sector, holds a Zacks Industry Rank of 146, placing it in the bottom 41% of over 250 industries [6]